Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China · Delayed Price · Currency is CNY 30.40
+0.56 (1.88%)
Aug 4, 2026, 3:00 PM CST
SHA:603590 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 917.99 | 915.12 | 825.4 | 920.01 | 866.73 | 809.78 |
Revenue Growth | 9.52% | 10.87% | -10.28% | 6.15% | 7.03% | 0.14% |
Gross Profit Gross Profit Growth | 824.75 | 822.87 | 739.14 | 818.96 | 740.07 | 704.02 |
Operating Income Operating Income Growth | 187.26 | 183.17 | 118.77 | 129.54 | 119.51 | 112.51 |
Net Income Net Income Growth | 168.68 | 165.97 | 42.22 | 150.45 | 101.49 | 147.99 |
Earnings Per Share EPS Growth | 1.06 | 1.04 | 0.27 | 0.96 | 0.65 | 0.94 |
EPS Growth | 270.41% | 285.19% | -71.88% | 47.69% | -30.85% | -18.26% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
East China East China Growth | 309.31 |
Southern China Southern China Growth | 92.44 |
North China North China Growth | 244.71 |
Central China Central China Growth | 94.83 |
Southwest Region Southwest Region Growth | 99.73 |
North-East Area North-East Area Growth | 18.51 |
North-West Region North-West Region Growth | 44.52 |
Overseas Areas Overseas Areas Growth | 10.18 |
Total Total Growth | 914.24 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 787.47 | 969.39 | 694.46 | 810.43 | 626.36 | 618.93 |
Total Debt Total Debt Growth | 330.92 | 320.16 | 209.67 | 149.78 | 12.42 | 18.62 |
Net Cash (Debt) Net Cash Growth | 456.56 | 649.23 | 484.79 | 660.65 | 613.94 | 600.31 |
Net Cash Growth | 21.25% | 33.92% | -26.62% | 7.61% | 2.27% | -60.08% |
Net Cash Per Share Net Cash Per Share Growth | 2.87 | 4.07 | 3.10 | 4.22 | 3.93 | 3.81 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 167.79 | 115.68 | 172.25 | 199.35 | 119.69 | 56.22 |
Capital Expenditures CapEx Growth | -39.88 | -53.45 | -104.02 | -100.91 | -96.31 | -164.65 |
Free Cash Flow Free Cash Flow Growth | 127.91 | 62.23 | 68.22 | 98.44 | 23.38 | -108.43 |
Free Cash Flow Growth | - | -8.79% | -30.70% | 321.05% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 89.84% | 89.92% | 89.55% | 89.02% | 85.39% | 86.94% |
Operating Margin | 20.40% | 20.02% | 14.39% | 14.08% | 13.79% | 13.89% |
Pretax Margin | 21.01% | 20.73% | 4.71% | 13.34% | 16.19% | 23.32% |
Profit Margin | 18.38% | 18.14% | 5.12% | 16.35% | 11.71% | 18.27% |
FCF Margin | 13.93% | 6.80% | 8.27% | 10.70% | 2.70% | -13.39% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.350 | 0.350 | 0.600 | 0.300 | 0.200 | 0.300 |
Dividend Per Share Growth | -41.67% | -41.67% | 100.00% | 50.00% | -33.33% | -14.29% |
Dividend Yield | 1.17% | 0.89% | 2.63% | 0.82% | 0.84% | 0.98% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 28.16 | 38.08 | 88.21 | 39.61 | 38.46 | 34.36 |
Forward PE | 26.41 | 37.32 | 17.89 | 34.78 | - | - |
P/FCF Ratio | 36.75 | 101.57 | 54.59 | 60.54 | 166.94 | - |
PS Ratio | 5.12 | 6.91 | 4.51 | 6.48 | 4.50 | 6.28 |